Contents

Search


T-cell prolymphocytic leukemia (TPLL)

Etiology: - occurs in younger patients with ataxia telangiectasia Epidemiology: - occurs both in adults as a sporadic disease & in younger patients with ataxia telangiectasia Pathology: - aggressive T cell leukemia - small to medium sized prolymphocytes with mature post-thymic T cell phenotype Classification: REAL classification: - T-cell chronic lymphocytic leukemia/prolymphocytic leukemia Immunophenotype: - Tdt -, CD1a - - CD2 +, CD3 +, CD7 + - CD4 + & CD8 - in ~60% - CD4 + & CD8 + in ~25% - CD4 - & CD8 + in ~15% Genetics: 1) T cell receptor gamma & beta chains clonally rearranged 2) rearrangements of chromosome 14q32.1 region involving TCL1B 3) MTCP1 overexpressed with t(X;14) translocation 4) associated with defects in ATM gene Clinical manifestations: - marked splenomegaly - lymphadenopathy - skin lesions - serous effusion Laboratgory: - high white blood cell count, predominance of prolymphocytes Management: - poor response to chemotherapy - short survival time

Interactions

disease interactions

General

chronic lymphocytic leukemia (CLL) peripheral T-cell lymphoid neoplasm prolymphocytic leukemia small lymphocytic lymphoma

References

  1. WHO Classification Tumours of Haematopoietic and Lymphoid Tissues. IARC Press 2001
  2. Shi M, Jevremovic D Lymphoma and plasma cell neoplasms T / NK cell disorders. T cell prolymphocytic leukemia http://www.pathologyoutlines.com/topic/lymphomanonBTcellpro.html